Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
- Market proximity of Strides Pharma International AG, based in Zug, Switzerland, opens the way for rapid technology transfer and innovation within the European market
- Oren Weininger, longstanding leader at Fairmed Healthcare, heads the business as CEO and Chairman of the Board
Zug, Switzerland. Strides Pharma Science Limited, globally recognized as a leading pharmaceutical company operating across 100 countries and headquartered in Bangalore, India, is consolidating its European business through Strides Pharma International AG, based in Zug, Switzerland.
Strides Pharma specializes in the development and manufacturing of IP-led niche finished dosage formulations. With over three decades of research and development expertise, Strides Pharma continuously develops and delivers products with innovative and improved technologies at competitive prices. Notably, Strides Pharma is among the world's largest manufacturers of Ibuprofen and Macrogol in various forms. Their unique range of drug delivery technologies opens up versatile and lucrative opportunities within the ever-evolving target markets.
The partner-centric in-licensing portfolio of over 250 formulations is consolidated in synergICE as a one-stop shop. It includes generics, sterile injectables and value-added products, Women´s Health hormones, lyophilized orally dissolving tablets and end-to-end biopharmaceutical CDMO services.
Oren Weininger, newly appointed Chairman of the Board, stated, “With this strengthened European B2B presence, we can respond faster to our customers’ needs and provide flexible, innovative solutions, and interesting generic portfolio, including comprehensive support in supply chain & quality management and regulatory processes by Strides Pharma International and the EU GMP-site in Hamburg, Germany.”
Key Markets are Central and Southern Europe (especially Germany), Scandinavia, Benelux and the Visegrád countries.
For further information, please visit: www.fair-med.com/newsroom
Contact Agency What About Now, Andreas Schöpf
as@whataboutnow.de Tel. +49 160 90723690
Following his roles at Dexcel Pharma and Kamedis, Oren Weininger took the position of CEO at Fairmed Healthcare AG in 2014 and subsequently became owner in 2018. Strides Pharma, after a period of successful partnership, invested in the company in 2019, further bolstering leading Fairmed Healthcare product lines. In addition to being appointed Chairman of the Board of Strides Pharma International AG, Weininger continues to lead Fairmed Healthcare GmbH in Hamburg.
Strides Pharma Science Limited, headquartered in Bangalore, India, was incorporated in 1990. The company has a global manufacturing footprint with eight facilities spread across four continents and a strong presence in 100 countries. Strides Pharma is a key active pharmaceutical ingredient manufacturer and producer of various products; every fourth Ibuprofen tablet on the global market today is supplied by Strides Pharma.
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Valle Venia presents Sandgrain in Space LPS feat. Lara5.12.2025 10:15:00 CET | Press Release
A Cosmic Song on Self Creation, Inner Rebirth, and the Quiet Power of Becoming Sandgrain in Space also gestures toward a vision of a “silent divine world,” a realm of clarity and heightened perception that emerges when inner turbulence dissolves. The silence referenced in the song is not emptiness but equilibrium, a moment of stillness in which the self hears itself without distortion. The song invites listeners to imagine this future world, one where illumination begins internally and radiates outward, influencing consciousness on a collective scale. This dimension gives the single an emotional resonance that extends beyond its space-driven imagery, grounding it in universal human longing for clarity, renewal, and transcendence. Musically, the single blends airy ambient textures with understated melodic movements that echo the vastness of its thematic concerns. The production opens with floating tonal fragments reminiscent of drifting light particles before expanding into luminous, sl
ARTE and Suspilne Ukraine sign an association agreement to strengthen cooperation4.12.2025 08:05:36 CET | Press Release
ARTE and Suspilne Ukraine have signed an association agreement to formalise their partnership, thereby opening a new chapter of cooperation — especially in co‑productions. The agreement was signed today on 3 December in Strasbourg by Heike Hempel, President of ARTE GEIE, Bruno Patino, Vice-President of ARTE GEIE and President of ARTE France and Mykola Chernotytskyi, Head of the Managing Board of Suspilne Ukraine. “This is an extraordinary day for ARTE – the association agreement with the Ukrainian public broadcaster Suspilne Ukraine moves us deeply and fills us with pride. Our two organisations share common goals and values, which the teams at Suspilne Ukraine are defending under the most challenging circumstances." - said Heike Hempel, President of ARTE GEIE. “This agreement strengthens ARTE’s network of partner channels across Europe and paves the way for numerous ambitious, high-quality co-productions. It also reflects our commitment to defending democratic values and fostering soli
The German advertising market is facing another year of stagnation in 20263.12.2025 12:42:00 CET | Press Release
The JOM Group’s latest advertising market forecast shows that the continuing economic uncertainty means that companies only have limited growth potential for increasing advertising investments. Hamburg, 2 December 2025 – The German advertising market is expected to close 2025 with a slight decline and will not achieve much growth in 2026 either. As stated by the JOM Group in its new forecast, the market turned out to be significantly less robust in the current year than was predicted at the end of 2024. Alongside the repeated downward revisions to expectations for overall economic growth and the consumer climate, advertising companies were noticeably less willing to invest. Issues such as customs policies and the crisis in the automotive industry once again illustrate how sensitive the market is in reacting to external disrupting factors. The JOM Group anticipates continued uncertainty from companies with regards to economic recovery and rising private consumer spending for 2026. Again
Change in leadership at Visable: Patrick Sostmann to take over from Peter F. Schmid as CEO of Visable Group on January 1, 20262.12.2025 09:35:00 CET | Press Release
Hamburg, December 2nd, 2025 – After more than 13 years at the helm of Visable, Peter F. Schmid will hand over leadership of the Visable Group to Patrick Sostmann, who has been CCO at Visable since June 2025, on January 1, 2026. Visable operates the B2B marketplaces wer liefert was (wlw) and europages. The handover at the top underscores the company's continuous development and its close partnership with Alibaba.com. Sostmann will continue to drive forward the strategy based on AI investments and user orientation, thereby expanding the B2B marketplaces into European market leaders in digital B2B business.
PLAN-B NET ZERO sets new standards in the energy market with Neo Energy25.11.2025 13:02:51 CET | Press Release
The Swiss green tech scale-up is positioning itself as a pioneer, transforming sustainable energy from a commodity into a digital lifestyle experience
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom